key: cord-0722981-496rymur
authors: Tannor, Elliot Koranteng; Bieber, Brian; Aylward, Ryan; Luyckx, Valerie; Shah, Dibya Singh; Liew, Adrian; Evans, Rhys; Phiri, Chimota; Guedes, Murilo; Pisoni, Ronald; Robinson, Bruce; Caskey, Fergus; Jha, Vivekanand; Pecoits-Filho, Roberto; Dreyer, Gavin
title: The COVID-19 pandemic identifies significant global inequities in hemodialysis care in Low and Lower Middle-Income countries - an ISN/DOPPS survey
date: 2022-03-11
journal: Kidney Int Rep
DOI: 10.1016/j.ekir.2022.02.027
sha: 2c5258d2cd938964499e72c792c6b76fc84aa38c
doc_id: 722981
cord_uid: 496rymur

INTRODUCTION: It is unknown how the COVID-19 pandemic has affected the care of vulnerable chronic hemodialysis (HD) patients across regions, particularly in low and lower-middle income (LLMIC) settings. We aimed to identify global inequities in HD care delivery during the COVID-19 pandemic. METHODS: The International Society of Nephrology(ISN) and Dialysis Outcomes and Practice Patterns Study(DOPPS) conducted a global online-survey of HD units between March and November, 2020 to ascertain practice patterns and access to resources relevant to HD care during the COVID-19 pandemic. Responses were categorized according to World Bank income classification for comparisons. RESULTS: Surveys were returned from 412 facilities in 78 countries: 15(4%) in Low Income Countries (LIC), 111(27%) in Lower-middle Income Countries (LMIC), 145(35%) in upper-middle income countries (UMIC) and 141(34%) in high-income countries (HIC). Respondents reported that diagnostic tests for SARS-CoV-2 were unavailable or of limited availability in LIC(72%) and LMICs(68%) as compared to UMIC(33%) and HIC(20%). The number of patients who missed HD treatments was reported to have increased during the COVID19 pandemic in LIC(64%) and LMIC(67%) as compared to UMIC(31%) and HICs(6%). Limited access to HD, intensive care unit (ICU) care and mechanical ventilation among hospitalized COVID-19 chronic dialysis patients was also reportedly higher in LIC and LMIC as compared to UMIC and HIC. Staff in LLMIC reported less routine testing for SARS-CoV-2 when asymptomatic as compared to UMIC and HIC - 14% in LIC and 11% in LMIC, compared to 26% and 28% in UMIC and HIC respectively. Severe shortages of PPE were reported by respondents from LIC and LMIC compared to UMIC and HIC, especially with respect to the use of the N95 particulate - air respirator masks. CONCLUSION: Striking global inequities were identified in the care of chronic HD patients during the pandemic. Urgent action is required to address these inequities which disproportionately affect LLMIC settings thereby exacerbating pre-existing vulnerabilities which may contribute to poorer outcomes.

The COVID-19 pandemic has had a devastating global impact on healthcare delivery, 1,2 disproportionally affecting low-and lower-middle income countries (LLMIC) as a result of longstanding insufficient healthcare investment, relatively poor healthcare infrastructure and low numbers of skilled health care workers. [3] [4] [5] The delivery of kidney replacement therapy, and in particular hemodialysis (HD), has been particularly challenging during this unprecedented period. 6 The mortality related to Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) infections in patients with kidney failure receiving kidney replacement therapies (dialysis and kidney transplantation) has been significantly higher than the mortality in the general population, ranging from 10-41%. [7] [8] [9] [10] [11] [12] [13] The risk of COVID-19 infection is particularly high in the HD population, due to the need for frequent visits to healthcare settings for treatments, inability to maintain social distancing during transportation and dialysis sessions in some dialysis units. 6, 7, 14, 15 Intrinsically fragile health care systems, lack of diagnostic testing for SARS-CoV-2, low staff numbers with high rates of staff sickness during the pandemic and shortage of personal protective equipment (PPE) have challenged LLMIC since the beginning of the pandemic. Additionally, increased costs needed for the implementation of protocols, transportation barriers caused by lockdowns and, healthcare professional burnout have potentiated the duration and magnitude of the effect of the pandemic on dialysis services. 16, 17 COVID-19 infection guidelines have been drawn up by various organizations including the Centre for Disease Control (CDC), European Renal Association -European Dialysis and Transplant Association and the United Kingdom Renal Association to guide clinicians to optimize patient and staff safety, prevent SARS-CoV-2 infection, and to manage patients with COVID-19 on HD. [18] [19] [20] [21] In addition, the African Association of Nephrology (AFRAN) published recommendations with a focus on LLMIC settings in Africa. 20 Successful implementation of such guidelines has been dependent on availability of the required resources and infrastructure, including but not limited to SARS-CoV-2 testing facilities, adequate personal protective equipment (PPE) for staff and patients, and isolation rooms within HD units for management of patients diagnosed with COVID-19. The provision of adequate resources to implement these guideline set against chronically underfunded health care systems may be a significant challenge in many LLMICs. 3 Inequities in health care delivery for patients with kidney failure on HD in LLMIC as compared to Uppermiddle Income Countries (UMIC) and High Income Countries (HIC), are likely to have been worsened by J o u r n a l P r e -p r o o f the COVID-19 pandemic. Data on such inequities will be important to advocate for directed improvements in HD care during and after the pandemic for better outcomes in the population living with kidney failure.

To the best of our knowledge, no study has systematically collected information on the ground across all income groups globally to support these assumptions. As such the International Society of Nephrology (ISN) and the Dialysis Outcomes and Practice Patterns Study (DOPPS) undertook an on-line survey to better understand the global challenges and inequities in HD care delivery consequent to the COVID-19

pandemic. The main objective of the present work was to describe global inequities in care of chronic haemodialysis patients according to the income status based on World Bank Classification as a tool for advocacy and change.

A survey to assess the impact of COVID-19 on dialysis services was developed by DOPPS and ISN investigators and administered in May-June 2020 to medical directors at sites participating in DOPPS Phase 7 In May 2020 (including 41 returns from China facilities) 22 . DOPPS and ISN agreed to extend the survey to countries not participating in DOPPS, including LLMIC. The ISN requested country membersocieties and registries to provide a list of dialysis units in their country, including HD and peritoneal dialysis (PD), private and public, university affiliated and non-affiliated, and hospital and satellite-based units. The adapted survey was subsequently disseminated to units in all countries in two stages: Participants consented to deidentified responses being securely stored on ISN and Arbor servers) see appendix 1 for confidentiality statement)

The study included 412 responses ( supplementary table 1 for list of responding countries). Overall, Africa had the highest number of responses -n=76 (18%) from 18 countries. Responses from LIC and LMIC were also mainly from Africa -n=11 (73%) and 53 (48%) respectively whereas responses from UMIC were mainly from North and East Asia -n=45 (31%), South

East and Asia and Oceania -n=27 (19%) Eastern/central Europe -n=22 (15%), and Latin America -n=21 (15%). HIC responses were mainly from Western Europe -n=59 (41%). The HD units of survey respondents were located in urban areas in country income groups as follows -LIC (100%) LMIC (79%), UMIC (88%) and HIC (67%). Sixty-seven percent of HD units were in the public sector in LIC, and in 40% of LMIC. HD was the sole kidney replacement therapy available in 87% of LIC and 79% of LMIC. Both HD and PD were available in 7% of LIC and 21% of LMIC as compared to 55% and 70% in UMIC and HIC respectively. ii. Interruption to haemodialysis delivery: As compared to pre-pandemic, respondents from HD facilities in LLMICs reported an increase in missed HD sessions for patients during the pandemic ( Figure 1 ). Transportation to and from HD units during the pandemic was reported to be more challenging by 31% of respondents from HD units in LIC and 38% in LMIC compared to 16% and 19% in UMIC and HIC respectively. Duration of HD sessions were reported to be more frequently reduced for logistic reasons or to limit exposure to SARS- infection who were on chronic HD (during versus before the pandemic) was reportedly more limited in LIC and LMIC as compared to UMIC and HIC ( Figure 2 ). Respondents reported that admitted patients in LIC and LMIC were less likely to be offered mechanical ventilation when required during versus before the pandemic ( Figure 2 ).

iv.

chronic HD: Respondents in 23% of LIC and 27% of LMIC reported confirmed or suspected COVID-19 cases in over 30% of patients as compared to 20% in UMIC and 11% in HIC ( Figure   3 ). Mortality was higher in LLMIC with 30% of respondents from LIC setting reporting greater than 50% mortality as compared to 8% of respondents in HIC ( Figure 4) . working HIC and UMIC were more likely to receive one-on-one private counselling in HIC (28%) and UMIC (27%) respectively compared to LIC (23%) and LMIC (16%) respectively.

The COVID-19 pandemic has global devastating consequences on health systems globally and has further highlighted and widened the gap of health care inequities between lower and upper income countries. 17, [24] [25] [26] This is the first report to study challenges in dialysis delivery during the COVID-19

pandemic across countries of different World Bank income status categories. 23 Our report identifies that there are important global inequities in the availability of diagnostic testing, availability and use of PPE, and restricted access dialysis sessions and ICU care in LLMICs as compared to non-LLMIC.

At the time of the survey, diagnostic testing for SARS-CoV-2 infection was not available or of limited availability for patients in LIC and LMIC as compared to UMIC and HIC. Many governments provide diagnostic testing for symptomatic patients but not for asymptomatic cases. 27 Most LLMIC had very few testing centers leading to backlogs and delay in results during the peak of the pandemic. 28 delays and inequities, respondents reported that patients in LLMIC were more likely to have to pay outof-pocket for diagnostic testing and that test results took longer to process. The cost of in-patient diagnostic testing has been shown to range from as low as $10 to as high as $1390 depending on the setting. 29 Reduced testing for COVID-19 infection among staff could lead to increased transmission in the HD unit among clinical staff and to already vulnerable patients with kidney failure. 15 Adequate provision and use of PPE is an important measure to prevent the spread of SARS-CoV-2. [18] [19] [20] [21] 30, 31 Staff in HD units in LLMIC reported that not only were they less frequently tested for SARS-CoV-2 infection when asymptomatic, but also reported shortages in the availability of PPE. Moreover, staff had to purchase PPE themselves and were more likely to use disposable PPE beyond the manufacturers stated shelf-life as compared to staff from UMIC and HIC.

Patients receiving HD in LLMIC reportedly missed their treatments more frequently than patients in UMIC and HIC. This was likely due to greater transportation challenges occurring in LLMIC during the peak of the pandemic, lack of work/funds, and severe local lockdowns and curfews. Such barriers have been described by others and can lead to death independent of infection with COVID-19. 32 In addition, it has been described that some private facilities in LLMIC refused to dialyze patients with symptoms suggestive of COVID-19, due to the perceived stigma of COVID-19 infection and lack of capacity to isolate patients with COVID-19 on dialysis. Referral of these patients to oversubscribed and under-resourced public hospitals likely further increased transmission risks in these facilities.. 33, 34 Access to in-patient care, ICU care or mechanical ventilation was reportedly more restricted for patients receiving HD in LLMIC. Generally, patients with kidney failure have multiple comorbidities and are assumed to have poor prognosis with high in-hospital mortality, especially when on chronic HD. [35] [36] [37] There is data suggesting that poor outcomes are not universal in patients with COVID-19 and kidney disease, once appropriate ICU care and mechanical ventilation are available. 38 Psychological support for HD staff was low in all settings but proportionally lower in LLMIC compared to UIC and HIC. Factors that have been shown to significantly increase psychological stress in healthcare staff are working in isolation wards, concern about acquiring COVID-19 infection in the workplace, shortages of PPE and staff working in direct contact with COVID-19 patients. 42 Respondents reported that during the pandemic staff in LLMIC had less guidance and training than elsewhere. Evidence suggests that increasing staff knowledge of infection prevention, development of protocols and educational activities can improve the morale among healthcare staff. 43 Adding to the already significant work-placebased stress, healthcare staff have been victims of stigma in some countries as they were assumed to have COVID-19 infection and were prevented from using public facilities and public transportation. 16, 44, 45 In the face of these psychological stressors with reduced support for the same in LLMIC, burnout and reduction in HD clinical staff should be expected as the pandemic continues.

The significant global reach of the ISN combined with the existing DOPPS networks and previous experience in capturing the reality of dialysis services across the globe is a major strength of this study.

Our findings are likely to be both generalizable and informative for policy makers as the pandemic progresses, and also in future healthcare crises. 47 We conclude that urgent action is required to address these inequities which disproportionately affect LLMIC settings thereby exacerbating pre-existing vulnerabilities which may contribute to poorer outcomes. In the modern era of medical practice and globalization, the existence and widening of such health inequities are unacceptable. In solidarity with patients living on HD and those who care for them, the nephrology community must urgently add its voice to the calls for global equity in access to all resources needed to detect and treat COVID-19 as well as to life-saving vaccinations. 

We would like to thank national Society and Registry country and ISN Regional Board leads who provided lists of dialysis centres that we were then able to contact. Supplementary Appendix 3 lists these contributors and surveyed respondents who wished to be acknowledged (NB we are unable to link respondents with individual responses). We are grateful to Charu Malik and Paul Laffin at ISN for their support, and Silvia Salaro at ISN who assisted with contacting country leads and deploying the survey. We J o u r n a l P r e -p r o o f 

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet

Managing COVID-19 in low-and middle-income countries

Global critical care: moving forward in resource-limited settings

Health care systems in low-and middle-income countries

COVID-19 and renal failure: challenges in the delivery of renal replacement therapy

COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza

A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection

Presentation and outcomes of patients with ESKD and COVID-19

Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study

Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion

Initial Effects of COVID-19 on Patients with ESKD

At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis

Stigma during the COVID-19 pandemic

Are overwhelmed health systems an inevitable consequence of covid-19? Experiences from China

Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres

21. NICE, National Institute for Health and Care Excellence (UK), NICE, National Institute for Health and Care Excellence (UK). COVID-19 rapid guideline: dialysis service delivery. NICE Guidelines

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey. Kidney International Reports 2021. 23. The World Bank by income and region. 2020. Accessed on

COVID-19 and the widening gap in health inequity

Covid-19-implications for the health care system

Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible

Assessing critical gaps in COVID-19 testing capacity: the case of delayed results in Ecuador

Diagnostic Tests Ranged from 10to 1390. Population Health Management

Minimizing the risk of COVID-19 among patients on dialysis

Protection of nephrology health professionals during the COVID-19 pandemic

Covid-19: collateral damage of lockdown in India

Challenges in Kidney Care in a Lower Middle Income Country During the COVID-19

Pandemic-the Ghanaian Perspective

The adverse effect of COVID pandemic on the care of patients with kidney diseases in India

Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City

COVID-19 and chronic renal disease: clinical characteristics and prognosis

Predictors of COVID-19 severity: A literature review

Mortality and renal outcomes of patients with severe COVID-19 treated in a provisional intensive care unit

A survey on critical care resources and practices in lowand middle-income countries

Intensive care for COVID-19 in low-and middle-income countries: research opportunities and challenges

Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study

Comment] COVID-19 pandemic and its impact on mental health of healthcare professionals

Community perspectives on the COVID-19 response

COVID-19-related stigma and perceived stress among dialysis staff

COVID-19 vaccines for low-and middle-income countries

Global COVID-19 vaccine inequity: The scope, the impact, and the challenges